key: cord-0873821-hoap1zeu
authors: Chakrabarti, Deep; Verma, Mranalini
title: Low-dose radiotherapy for SARS-CoV-2 pneumonia
date: 2020-05-11
journal: Strahlenther Onkol
DOI: 10.1007/s00066-020-01634-8
sha: 33e5098fd9bff926e388f44f8858faacf5acde09
doc_id: 873821
cord_uid: hoap1zeu

nan

While most of our knowledge on the use of X-radiation to treat pneumonia comes from case reports and case series published more than half a century ago which do not count as robust evidence in the present day [3] , the prospects seem promising under the current circumstances. A single fraction of low-dose radiotherapy is cost and time effective and could potentially alleviate symptoms of respiratory distress quickly, helping to reduce mortality without significant long-term sequelae. This, in turn, facilitates early discharge from hospital and reduces costs of in-patient hospitalisation, ultimately leading to better resource utilisation in the face of a global emergency. The strategy merits international cooperation and rapid evaluation in a randomised controlled trial. For a pandemic that originated in Hubei, one can look to the Chinese philosopher Confucius for words of wisdom: "Study the past if you would define the future". The past may indeed hold the key.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China : a descriptive study

How radiotherapy was historically used to treat pneumonia: could it be useful today?

Radiotherapy treatment of human inflammatory diseases and conditions: optimal dose

DEGRO practical guidelines for radiotherapy of non-malignant disorders: Part I: physical principles, radiobiological mechanisms, and radiogenic risk

Low-dose radiation therapy for benign pathologies

Anti-inflammatory effect of low-dose X-irradiation and the involvement of a TGF-beta1-induced down-regulation of leukocyte/endothelial cell adhesion

Low-dose hyper-radiosensitivity: past, present, and future

Conflict of interest D. Chakrabarti and M. Verma declare that they have no competing interests.